Synbiotic as an Adjuvant Therapy for Dyslipidaemia and Gut Health
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 190 participants.
Also called NCT07915687
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 190 participants
- Sponsor
- Universiti Teknologi Mara
- Registry
-
NCT07915687
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Malaysia
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07915687. Randomized; quadruple masking; primary purpose treatment. Start 2026-12-02 (anticipated); primary completion 2027-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Synbiotic as an Adjuvant Therapy for Dyslipidaemia and Gut Health
- Condition
- Dyslipidemia
- Intervention (Dietary supplement)
- Synbiotic (LAB12 and SWEOAT® Bran)
- Intervention (Other)
- Oat-based Placebo
- Lead sponsor
- Universiti Teknologi Mara
- Collaborator
- Dong Foong Manufacturing Sdn. Bhd.
Record details
- Record id
cardio:ct-nct07915687- Content hash
f1438678b55a54aebc4e91e4356ba6d45e170b574f572a8de1c6cbb01010d91b